Technology, data, and design are great, but it's clinical outcomes that really matter.
Our published weight loss outcomes for our at-risk disease program demonstrate a significant reduction in risk for three chronic diseases: 
After the first 16-week intensive phase, participants who completed the Omada at-risk disease program lose around 4% of their body weight on average and about forty percent lose 5% or more. And our two-year data shows they've kept most of it off. 
ROI positive as little as 1 year.
Three recent independent claims analyses for our pre-chronic disease program demonstrate how quickly employers could recoup their investment in Omada. 
Omada does not accept unsolicited research proposals; we will consider proposals that meet one of our targeted areas of interest.
Improve your population's health and lower medical spend with our prevention-based framework.